Evaluation of pharmacy-based HIV testing in a high-risk New York City community by S Amesty et al.
POSTER PRESENTATION Open Access
Evaluation of pharmacy-based HIV testing in
a high-risk New York City community
S Amesty*, N Crawford, V Nandi, A Rivera, C Fuller
From International Symposium HIV and Emerging Infectious Diseases 2014
Marseille, France. 21-23 May 2013
Introduction
Injection drug users (IDUs) face limited access to HIV
testing and experience delayed HIV diagnoses. New
York City (NYC) pharmacies play an important role in
HIV prevention among IDUs through the Expanded
Syringe Access Program (ESAP), which provides access
to sterile syringes without a prescription. We examined
in-pharmacy HIV testing among syringe/non-syringe
customers in ESAP pharmacies in NYC.
Materials and methods
Syringe/non-syringe pharmacy customers were recruited
in two ESAP community pharmacies in high HIV preva-
lence neighborhoods to complete a 30-minute survey.
In-pharmacy HIV testing was offered to all HIV-negative
participants. Descriptive statistics, chi-square and Fisher’s
exact tests were performed for categorical outcomes and
t-tests for continuous outcomes to determine significant
differences in individual characteristics between patrons
who accepted in-pharmacy HIV testing compared with
those who declined. Stepwise multivariable logistic regres-
sion was used to assess the relationship between receiving
in-pharmacy HIV testing and customer characteristics
identified from bivariate analyses.
Results
Of 327 participants, most were male (57%), black (80%),
had ever used hard drugs (88%); 217 (66.4%) were HIV-
negative, and 39.6% received in-pharmacy HIV testing.
After adjustment, being female (AOR 2.71; 95% CI
1.44-5.10), having multiple sex partners (AOR 1.31; 95%
CI 1.08-1.59), having an HIV test more than 12 months
ago (AOR 2.90; 95% CI 1.30-6.47), injecting drugs (AOR
2.26; 95% CI 1.04-4.91), and seeing the same regular
medical provider (AOR 0.33; 95% CI 0.17-0.67) were
associated with receiving in-pharmacy HIV test.
Conclusions
This study presents evidence for a potential new venue
for HIV testing that could provide access for hard-to-
reach populations that have limited access to HIV testing.
The approach we used was feasible to pharmacists. Given
that pharmacies are located everywhere in NYC and have
access to new point-of-care and home-based HIV testing
technologies, the provision of HIV testing in pharmacies
could provide easy access to HIV testing for IDUs as well
as other populations.
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